Literature DB >> 29681025

Major Differences in Neurooxidative and Neuronitrosative Stress Pathways Between Major Depressive Disorder and Types I and II Bipolar Disorder.

Michael Maes1,2,3,4, Kamila Landucci Bonifacio5, Nayara Rampazzo Morelli5, Heber Odebrecht Vargas5, Décio Sabbatini Barbosa5, André F Carvalho6,7, Sandra Odebrecht Vargas Nunes5.   

Abstract

Accumulating evidence indicates that oxidative and nitrosative stress (O&NS) pathways play a key role in the pathophysiology of bipolar disorder (BD) and major depressive disorder (MDD). However, only a handful of studies have directly compared alterations in O&NS pathways among patients with MDD and BD types I (BPI) and BPII. Thus, the current study compared superoxide dismutase (SOD1), lipid hydroperoxides (LOOH), catalase, nitric oxide metabolites (NOx), malondialdehyde (MDA), and advanced oxidation protein products (AOPP) between mood disorder patients in a clinically remitted state. To this end 45, 23, and 37 participants with BPI, BPII, and MDD, respectively, as well as 54 healthy controls (HCs) were recruited. Z-unit weighted composite scores were computed as indices of reactive oxygen species (ROS) production and nitro-oxidative stress driving lipid or protein oxidation. SOD1, NOx, and MDA were significantly higher in MDD than in the other three groups. AOPP was significantly higher in BPI than in HCs and BPII patients. BPII patients showed lower SOD1 compared to all other groups. Furthermore, MDD was characterized by increased indices of ROS and lipid hydroperoxide production compared to BPI and BPII groups. Indices of nitro-oxidative stress coupled with aldehyde production or protein oxidation were significantly different among the three patient groups (BDII > BDI > MDD). Finally, depressive symptom scores were significantly associated with higher LOOH and AOPP levels. In conclusion, depression is accompanied by increased ROS production, which is insufficiently dampened by catalase activity, thereby increasing nitro-oxidative damage to lipids and aldehyde production. Increased protein oxidation with formation of AOPP appeared to be hallmark of MDD and BPI. In addition, patients with BPII may have protection against the damaging effects of ROS including lipid peroxidation and aldehyde formation. This study suggests that biomarkers related to O&NS could aid in the differentiation of MDD, BPI, and BPII.

Entities:  

Keywords:  Bipolar disorder; Depression; Immune; Inflammation; Oxidative and nitrosative stress

Mesh:

Substances:

Year:  2018        PMID: 29681025     DOI: 10.1007/s12035-018-1051-7

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  16 in total

1.  Efficacy of folic acid as an adjunct to lithium therapy on manic-like behaviors, oxidative stress and inflammatory parameters in an animal model of mania.

Authors:  Samira Menegas; Gustavo C Dal-Pont; José H Cararo; Roger B Varela; Jorge M Aguiar-Geraldo; Taise Possamai-Della; Monica L Andersen; João Quevedo; Samira S Valvassori
Journal:  Metab Brain Dis       Date:  2019-12-15       Impact factor: 3.584

2.  Towards a new model and classification of mood disorders based on risk resilience, neuro-affective toxicity, staging, and phenome features using the nomothetic network psychiatry approach.

Authors:  Michael Maes; Juliana Brum Moraes; Kamila Landucci Bonifacio; Decio Sabbatini Barbosa; Heber Odebrecht Vargas; Ana Paula Michelin; Sandra Odebrecht Vargas Nunes
Journal:  Metab Brain Dis       Date:  2021-01-07       Impact factor: 3.584

Review 3.  Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry.

Authors:  G Morris; A J Walker; K Walder; M Berk; W Marx; A F Carvalho; M Maes; B K Puri
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

4.  Increased Serum Immunoglobulin Responses to Gut Commensal Gram-Negative Bacteria in Unipolar Major Depression and Bipolar Disorder Type 1, Especially When Melancholia Is Present.

Authors:  Denitsa Simeonova; Drozdstoy Stoyanov; Jean-Claude Leunis; Andre F Carvalho; Marta Kubera; Marianna Murdjeva; Michael Maes
Journal:  Neurotox Res       Date:  2019-12-04       Impact factor: 3.911

5.  Inflammation and nitro-oxidative stress in current suicidal attempts and current suicidal ideation: a systematic review and meta-analysis.

Authors:  Asara Vasupanrajit; Ketsupar Jirakran; Chavit Tunvirachaisakul; Marco Solmi; Michael Maes
Journal:  Mol Psychiatry       Date:  2022-01-08       Impact factor: 13.437

6.  Impairments in Peripheral Blood T Effector and T Regulatory Lymphocytes in Bipolar Disorder Are Associated with Staging of Illness and Anti-cytomegalovirus IgG Levels.

Authors:  Michael Maes; Joao Victor Nani; Cristiano Noto; Lucas Rizzo; Mirian A F Hayashi; Elisa Brietzke
Journal:  Mol Neurobiol       Date:  2020-09-11       Impact factor: 5.590

7.  Vorinostat (SAHA) May Exert Its Antidepressant-Like Effects Through the Modulation of Oxidative Stress Pathways.

Authors:  Paulina Misztak; Magdalena Sowa-Kućma; Bernadeta Szewczyk; Gabriel Nowak
Journal:  Neurotox Res       Date:  2021-01-05       Impact factor: 3.911

8.  Increased Oxidative Stress Toxicity and Lowered Antioxidant Defenses in Temporal Lobe Epilepsy and Mesial Temporal Sclerosis: Associations with Psychiatric Comorbidities.

Authors:  Michael Maes; Thitiporn Supasitthumrong; Chusak Limotai; Ana Paula Michelin; Andressa Keiko Matsumoto; Laura de Oliveira Semão; João Victor de Lima Pedrão; Estefânia Gastaldello Moreira; Andre F Carvalho; Sunee Sirivichayakul; Décio Sabbatini Barbosa; Buranee Kanchanatawan
Journal:  Mol Neurobiol       Date:  2020-06-09       Impact factor: 5.682

9.  Association between arginine catabolism and major depressive disorder: A protocol for the systematic review and meta-analysis of metabolic pathway.

Authors:  Bing Cao; Runze Deng; Dongfang Wang; Li Li; Zhongyu Ren; Lixin Xu; Xiao Gao
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

Review 10.  Antioxidants: Positive or Negative Actors?

Authors:  Bahare Salehi; Miquel Martorell; Jack L Arbiser; Antoni Sureda; Natália Martins; Pawan Kumar Maurya; Mehdi Sharifi-Rad; Pradeep Kumar; Javad Sharifi-Rad
Journal:  Biomolecules       Date:  2018-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.